Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis

por Hsu, Ya-Ling, Hung, Jen-Yu, Lee, Yen-Lung, Chen, Feng-Wei, Chang, Kuo-Feng, Chang, Wei-An, Tsai, Ying-Ming, Chong, Inn-Wen, Kuo, Po-Lin
Publicado 2017

Correction: Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis

por Hsu, Ya-Ling, Hung, Jen-Yu, Lee, Yen-Lung, Chen, Feng-Wei, Chang, Kuo-Feng, Chang, Wei-An, Tsai, Ying-Ming, Chong, Inn-Wen, Kuo, Po-Lin
Publicado 2019

Port type is a possible risk factor for implantable venous access port-related bloodstream infections and no sign of local infection predicts the growth of gram-negative bacilli

por Hsu, Jui-Feng, Chang, Hsu-Liang, Tsai, Ming-Ju, Tsai, Ying-Ming, Lee, Yen-Lung, Chen, Pei-Huan, Fan, Wen-Chieh, Su, Yu-Chung, Yang, Chih-Jen
Publicado 2015

CD44 Promotes Lung Cancer Cell Metastasis through ERK–ZEB1 Signaling

por Wang, Yen-Yun, Vadhan, Anupama, Chen, Ping-Ho, Lee, Yen-Lung, Chao, Chih-Yeh, Cheng, Kuang-Hung, Chang, Yu-Chiuan, Hu, Stephen Chu-Sung, Yuan, Shyng-Shiou F.
Publicado 2021

Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib

por Tsai, Ming-Ju, Hung, Jen-Yu, Ma, Juei-Yang, Tsai, Yu-Chen, Wu, Kuan-Li, Lee, Mei-Hsuan, Kuo, Chia-Yu, Chuang, Cheng-Hao, Lee, Tai-Huang, Lee, Yen-Lung, Huang, Chun-Ming, Shen, Mei-Chiou, Yang, Chih-Jen, Chong, Inn-Wen
Publicado 2023